Sierra Oncology, Inc. Recorded Big Gain

Wed, Apr 13, 2022 at 05:30 PM
Sierra Oncology, Inc. Recorded Big Gain

Sierra Oncology, Inc. (SRRA:NASDAQ) soared at $54.75, representing a gain of 38.5%. On Tue, Apr 12, 2022, SRRA:NASDAQ hit a New 2-Week High of $39.52. The stock appeared on our News Catalysts scanner on Wed, Apr 13, 2022 at 02:06 PM in the 'ACQUISITION' category. From Tue, Mar 29, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days

About Sierra Oncology, Inc. (SRRA:NASDAQ)

Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.